Summary A case-control study of 10,228 gestational women was conducted in Lanzhou, China, between 2010 and 2012. This study aimed to evaluate the associations between the risk of gestational hypertensive disorders and dietary intake of vitamin C/E. Among this study's participants, 5.41% (n5553) were diagnosed with gestational hypertensive disorders. Of these disorders, 69.44% (n5384) were preeclampsia and 30.56% (n5169) were considered to be gestational hypertension. After adjustment for confounding variables and other relevant dietary nutrients, no association was found between the risk of gestational hypertensive disorders and dietary intake of vitamin C, vitamin E, copper or manganese before or during pregnancy. However, zinc and selenium intake was associated with the decrease risk of gestational hypertensive disease during different stages of pregnancy (p,0.05). Gestational dietary intake of zinc and selenium can significantly decrease the risk of gestational hypertensive disorders. No association was found between gestational hypertensive disorders and vitamin C, vitamin E, copper or manganese intake.
Gestational hypertension is defined as a systolic blood pressure greater than 140 mmHg or a diastolic blood pressure greater than 90 mmHg observed in previously normotensive pregnant women after 20 wk of gestation in the absence of proteinuria. In the presence of at least 300 mg proteinuria within a 24-h period, the patient is diagnosed with preeclampsia, a disorder with a reported prevalence of 5-10% among pregnant women (1, 2) . Gestational hypertension is one of the most severe pregnancy complications and is the leading cause of maternal morbidity and mortality worldwide (3) . Many potential factors have been considered in relation to gestational hypertension, such as maternal age, previous history of hypertension, body mass index before pregnancy, family history of hypertension, family history of gestational hypertension and multivitamin consumption (4) .
Oxidative stress is defined as an imbalanced capacity between oxidants and antioxidants in the body. Reactive oxygen species (ROS) are especially reactive and can interact with lipids, proteins and DNA to initiate different pathological processes. Previous studies have shown that ROS can exaggerate systemic inflammation by inducing endothelial dysfunction, leading to the clinical symptoms of gestational hypertension and preeclampsia (5, 6) . Because of the increased metabolic demands during pregnancy and the requirements of the fetus, insufficient supplies of micronutrients and essential vitamins can lead to a biological competition between the fetus and the mother. Therefore, the nutritional status of the mother can influence her health status, as well as that of the fetus.
Researchers have shown that deficiency of micronutrients during pregnancy is related to clinical outcomes. Antioxidant deficiency, such as zinc, selenium, copper, manganese, vitamin C (ascorbic acid) and vitamin E (alpha-tocopherol), was significantly associated with poor pregnancy outcomes, including preeclampsia and fetal growth restriction (7, 8) . Vitamin C and vitamin E are two essential antioxidants that can effectively scavenge free radicals and constitute a strong line of defense in retarding reactive ROS-induced cellular damage (9) . Vitamins C and E also play a key role in enzyme modulation involved in vascular endothelial damage and are known to contribute to the pathophysiological mechanisms of the clinical expression of preeclampsia (10) . Previous studies have demonstrated a synergistic effect between these two vitamins (11) . Some studies reported that plasma levels of ascorbic acid and serum antioxidant activities were significantly lower in women with preeclampsia, after adjusting for maternal age, parity, body mass index before pregnancy, and energy intake (11) (12) (13) (14) . Some studies reported that a reduced level of vitamin E was significantly associated with preeclampsia (15) (16) (17) . However, it is still unclear whether antioxidant trace elements can reduce the risk of gestational hypertension and preeclampsia. Some previous studies indicated the antioxidant activities of these elements, but most of the research evaluated the serum vitamin level (18, 19) .
This study aimed to evaluate the association between antioxidants from dietary intake, such as vitamin C and vitamin E, zinc, selenium, copper and manganese, and the risk of developing gestational hypertensive disorders.
MATERIALS AND METHODS
A case-control study was conducted with pregnant women who had been referred to Gansu Provincial Maternity and Child-care Hospital (GPMCCH) from 2010 to 2012. All participants were women (older than 18 y) who visited the hospital at more than 20 wk gestation, were diagnosed with gestational hypertension or preeclampsia by a physician, and had no medical history of hypertension or mental illness before pregnancy.
The study sample was 14,535 pregnant women, where 176 of them were considered to be ineligible for our study (13 had mental illness, 39 were younger than 18 y, and 124 gave birth at less than 20 gestational weeks). Moreover, 3,721 patients refused to take part in the program, and an additional 105 people did not attend a valid in-person interview. Therefore, a total of 10,542 (73.4%) pregnant women were left to participate in our research, and ultimately, 10,179 of the cases resulted in singleton live birth.
All staff members were trained uniformly and professionally prior to collecting data for the study. A designed, standardized, and structured questionnaire was available for the in-person interview. Information about demographic characteristics, smoking, alcohol and tea consumption, gestational age, family history of hypertension, previous pregnancy hypertension, reproductive and medical history, occupational exposure and residential environment, physical activity and dietary situation were obtained from participants during the interview. Most interviews were conducted after delivery (84%).
The program was approved by the Ethics Committees of GPMCCH and the approval number was KY2010EAY-2. All research procedures complied with the code of ethics of the World Medical Association.
All analyses were performed using SAS software, version 9.2. Demographic characteristics were evaluated between the case and control groups by either the chi-square test or Fisher's exact test for categorical variables. Odds ratios (OR) and 95% confidence intervals (95% CI) were used to estimate the association between dietary vitamin C/E and gestational hypertension or preeclampsia by unconditional logistic regression models. Potential confounding variables, including maternal age (,25, 25-30, 30-35 , $30 y), years of education (,10, 10-15, .15), total energy intake during pregnancy, employment status during pregnancy (yes or no), gestational diabetes (yes or no), parity (nulliparous or parous), weight gain during pregnancy, prepregnancy BMI, smoking during pregnancy (passive or active), family history of hypertension, and history of mother's gestational hypertension were adjusted in the final models.
RESULTS
A total of 10,228 participants were validated for the study after screening. Of these participants, 5.41% (n5553) were diagnosed with gestational hypertensive disorders, 69.44% (n5384) were diagnosed with preeclampsia and 30.56% (n5169) were diagnosed with gestational hypertension. Table 1 shows the distribution of selected characteristics of the study population. Pregnant women who developed gestational hypertensive disorders, compared to healthy pregnant women, were greater in age, parity, BMI before pregnancy, and weight gain during pregnancy, but less in monthly income per capita. Women who took multivitamins before pregnancy had a low rate of gestational hypertension. Additionally, gestational women with family history of hypertension or gestational hypertension were more likely to experience gestational hypertensive disease. However, the distribution of active or passive smoking was similar between women with gestational hypertensive disorders and healthy pregnant women. Table 2 presents the results from the conditional logistic regression for dietary anti-oxidative nutrients intake, which evaluated vitamin C, vitamin E, zinc, selenium, copper and manganese on the development of gestational hypertension or preeclampsia. No significant difference was found between the risk of gestational hypertensive disorders and dietary intake of vitamin E, copper before pregnancy, or vitamin C before or during pregnancy. Vitamin E, zinc, selenium, copper and manganese intake during pregnancy showed a significant positive association with developing gestational hypertensive disorders, after adjusting for confounding variables.
However, after adjustment for confounding variables and dietary intake of every nutrient in Table 3 , only zinc and selenium intake before pregnancy showed positive association with gestational hypertensive disease. Table 4 shows the results from the conditional logistic regression that was performed in order to investigate which factors remain associated with preeclampsia development. After adjustment for confounders, dietary intake of zinc, selenium, manganese before and during pregnancy, vitamin E during the first and third trimesters and copper during pregnancy were associated with the development of preeclampsia. No significant difference was found between the risk of preeclampsia and dietary intake of vitamin C before or during pregnancy. After adjustment for confounders and every antioxidant, none of these dietary nutrients had an association with the development of preeclampsia, except for zinc intake during the first trimester or before pregnancy, as shown in Table 5 .
As shown in Table 6 , logistic regression was performed to determine whether dietary intake of antioxidants during the first trimester could predict the risk of developing gestational hypertension later in pregnancy. After adjustment for confounders, dietary intake of zinc and copper during pregnancy, as well as selenium intake before and during pregnancy, was positively associated with the risk of the gestational hypertension. Additionally, dietary intake of vitamin C during the first and third trimesters and manganese during second and third trimesters also weakly influenced the development of gestational hypertension. However, after adjustment for confounders and every antioxidant shown in Table  7 , only dietary intake of vitamin C during the first trimester was associated with gestational hypertension. All the groups in this study were grouped by quantiles of anti-oxidative nutrients intake in different trimester. The data of every quantile was shown in Table 8 .
DISCUSSION
Studies have confirmed that free radical-mediated lipid peroxidation can be involved in the type of endothelial damage seen in preeclampsia (20, 21) . In addition to the enzymatic mechanisms for antioxidation and radical removal, essential nutrients from dietary intake can scavenge free radicals to constitute a strong line of defense in retarding cellular damage induced by free radicals (22) . Some researchers have suggested that lower intakes of vitamin C and vitamin E were related to an increased risk of pregnancy-induced hypertension (13, 23) . Another study reported lower intakes of vitamin C and vitamin E in women with preeclampsia and higher intakes in women with gestational hypertension (4). In our study, no association was found between dietary intake of vitamin C or vitamin E during pregnancy and the risk of gestational hypertensive disorders. The result was consistent with most previous studies (24) (25) (26) . However, before adjustment for every relevant antioxidant, vitamin E also showed a weak association with the risk of gestational hypertensive disorders. Therefore, such a result may have resulted from the multicollinearity of those antioxidants. One explanation for these conflicting findings may be in the methodology used to assess dietary intake, where some stud- Adjusted for maternal age, education level, parity, maternal BMI before pregnancy, weight gain during pregnancy, family monthly income per capita, family history of hypertension, family history of gestational hypertension, smoking and multivitamin intake before or during pregnancy and each antioxidant. Adjusted for maternal age, education level, parity, maternal BMI before pregnancy, weight gain during pregnancy, family monthly income per capita, family history of hypertension, family history of gestational hypertension, smoking and multivitamin intake before or during pregnancy and each antioxidant. ies have used the 24-h recall method compared with a food frequency questionnaire. These findings may also be due to differences in gestational age at the time of the dietary assessment. For dietary intake of zinc, this study found that only intake before pregnancy was related to a significantly decreased risk of gestational hypertensive disease and preeclampsia. However, no association with gestational hypertension was found after adjustment for confounders and each concerned antioxidative nutrient. Zinc intake during pregnancy was found to have no association between them. These results are partly consistent with the result reported by Kazemian et al. (3) , which found no association between the risk of gestational hypertensive disorders and dietary intake of zinc. Tande et al. (1) . also reported that dietary zinc intake did not vary between women with gestational hypertension and those who had a normotensive pregnancy when serum zinc was significantly different. However, not enough studies have been completed to verify the role of dietary intake of zinc in mitigating risk of gestational hypertensive disease. Many previous studies investigated the association between the serum/plasma zinc and gestational hypertensive disorders. The main result of those studies was that no difference in maternal zinc status between gestational women with a hypertensive disorder and those without was found (27) (28) (29) .
For selenium, copper and manganese, this study observed no associations with the risk of gestational hypertensive disorders, except for selenium before pregnancy after adjusting for confounders and every concerned antioxidant. Most previous studies have been done though serum/plasma selenium and their results were not consistent. Some investigations found that maternal selenium level was associated with preeclampsia while others considered that there was no association between selenium and gestational hypertensive disorders (30) . Therefore, further study is needed to investigate the influence of dietary selenium intake on gestational hypertensive disorders. Meanwhile, we failed to find any more evidence that dietary intake of copper or manganese can decrease the risk of gestational hypertensive disorders.
We also compared the difference between women with gestational hypertensive disorders and normotensive pregnant women by stratification analysis of maternal age, BMI before pregnancy and parity (primipara or not). After adjustment for confounders and every antioxidant, dietary intake of zinc before pregnancy and during the first trimester showed a significant difference in gestational hypertensive disorders before pregnancy between the case and control groups when the maternal age was less than 30 y old. However, in women older than 30 y, dietary intake of vitamin E during the second trimester unexpectedly showed a negative effect on the risk of gestational hypertensive disorders. For women with a BMI before pregnancy less than 24 kg/m 2 , only dietary intake of zinc before and during pregnancy was associated with the gestational hypertensive disorders. However, for women with a BMI before pregnancy greater than 24 kg/m 2 , dietary intake of selenium was shown to be a protective factor. In addition, our results indicate that dietary intake of vitamin E has a negative association with gestational hypertensive disorders for primipara. However, for multipara, dietary intake of selenium before pregnancy and zinc during the third trimester might have a positive effect. The strength of our study is that it primarily explored the association between dietary anti-oxidative nutrients intake and gestational hypertensive disorders by considering the influence of dietary intake on four different stages of pregnancy. One limitation of the study was the case-control design, which could not determine cause and effect relationships between groups. Additionally, this study did not measure blood levels of nutrient biomarkers.
In summary, this study showed no association between the risk of gestational hypertensive disorders and dietary intake of vitamin C or vitamin E. However, these results indicate a preventive effect of dietary zinc and selenium intake on the risk of gestational hypertension disease.
